We successfully licensed out our pipeline to a major ophthalmology company in China!

We successfully licensed out our pipeline to a major ophthalmology company in China! pic.twitter.com/VfN7SHcuxH

— kazuo tsubota (@TsubotaLab) September 6, 2024